Organogenesis Reverse Merges with Avista Healthcare Public Acquisition Corp. (AHPAC)

 Organogenesis Reverse Merges with Avista Healthcare Public Acquisition Corp. (AHPAC)

Organogenesis Reverse Merges with Avista Healthcare Public Acquisition Corp. (AHPAC)

Shots:
  • With the closure of transaction Organogenesis, will be a public offering in NSE as “ORGO”
  • The collaboration compromises of an initial enterprise value of ~$673mn, making Organogenesis to be wholly owned by AHPAC
  • Avista Capital Partners agreed to invest $92mn in the collaboration of companies, further used in product portfolio and R&D
Click here to read full press release/ article | Ref: Organogenesis Inc. | Image:  PRNewsWire

Vartika Singh

Vartika Singh is a content writer who loves to write research articles and reports at PharmaShots. She has in-depth knowledge of the life sciences industry including the Pharma and Biotech sectors. Any articles written by her can be contacted at connect@pharmashots.com.

Related post